BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024
BiomX Inc. (NYSE American: PHGE), a clinical-stage company developing novel natural and engineered phage therapies targeting specific pathogenic bacteria, has announced a conference call and live audio webcast scheduled for August 15, 2024, at 8:00 a.m. ET. The purpose of this event is to report the company's second quarter 2024 financial results and provide updates on its business and programs.
Interested parties can participate in the conference call by dialing 1-877-407-0724 (U.S.) or 1-201-389-0898 (International). Additionally, a live and archived webcast will be available in the Investors section of the BiomX website at www.biomx.com.
BiomX Inc. (NYSE American: PHGE), un'azienda in fase clinica che sviluppa nuove terapie con fagi naturali e ingegnerizzati mirate a batteri patogeni specifici, ha annunciato una conferenza telefonica e una diretta audio webcast programmata per 15 agosto 2024, alle 8:00 EST. Lo scopo di questo evento è riportare i risultati finanziari del secondo trimestre 2024 e fornire aggiornamenti sulle attività e i programmi dell'azienda.
Le parti interessate possono partecipare alla conferenza telefonica componendo 1-877-407-0724 (USA) o 1-201-389-0898 (Internazionale). Inoltre, una diretta e un webcast archiviato saranno disponibili nella sezione Investitori del sito web di BiomX all'indirizzo www.biomx.com.
BiomX Inc. (NYSE American: PHGE), una empresa en etapa clínica que desarrolla nuevas terapias de fagos naturales e ingenierizados dirigidas a bacterias patógenas específicas, ha anunciado una conferencia telefónica y una transmisión en vivo programada para el 15 de agosto de 2024, a las 8:00 a.m. ET. El propósito de este evento es informar sobre los resultados financieros del segundo trimestre de 2024 y proporcionar actualizaciones sobre sus negocios y programas.
Las partes interesadas pueden participar en la conferencia telefónica marcando 1-877-407-0724 (EE.UU.) o 1-201-389-0898 (Internacional). Además, habrá una transmisión en vivo y un webcast archivado disponibles en la sección de Inversores del sitio web de BiomX en www.biomx.com.
BiomX Inc. (NYSE American: PHGE)는 특정 병원성 박테리아를 겨냥한 새로운 자연 및 공학적 파지 치료법을 개발하는 임상 단계 회사로, 2024년 8월 15일 오전 8시 ET에 예정된 컨퍼런스 콜 및 라이브 오디오 웹캐스트를 발표했습니다. 이 이벤트의 목적은 회사의 2024년 2분기 재무 결과를 보고하고 비즈니스 및 프로그램에 대한 업데이트를 제공하는 것입니다.
관심 있는 분들은 1-877-407-0724 (미국) 또는 1-201-389-0898 (국제)로 전화하여 컨퍼런스 콜에 참여할 수 있습니다. 또한, BiomX 웹사이트의 투자자 섹션에서 www.biomx.com에 라이브 및 아카이브된 웹캐스트가 제공될 것입니다.
BiomX Inc. (NYSE American: PHGE), une entreprise en phase clinique développant de nouvelles thérapies phagiques naturelles et ingénierées ciblant des bactéries pathogènes spécifiques, a annoncé une conférence téléphonique et un webinaire audio en direct prévu pour le 15 août 2024 à 8h00 ET. L'objectif de cet événement est de présenter les résultats financiers du deuxième trimestre 2024 et de fournir des mises à jour sur ses activités et programmes.
Les parties intéressées peuvent participer à la conférence téléphonique en composant 1-877-407-0724 (États-Unis) ou 1-201-389-0898 (International). De plus, un webinaire en direct et une rediffusion seront disponibles dans la section Investisseurs du site web de BiomX à l'adresse www.biomx.com.
BiomX Inc. (NYSE American: PHGE), ein Unternehmen in der klinischen Phase, das neuartige natürliche und gentechnisch veränderte Phagentherapien zur Bekämpfung spezifischer pathogener Bakterien entwickelt, hat eine Telefonkonferenz und eine Live-Audio-Webcast für den 15. August 2024 um 8:00 Uhr ET angekündigt. Der Zweck dieser Veranstaltung ist es, die finanziellen Ergebnisse für das zweite Quartal 2024 zu berichten und Updates zu den Geschäften und Programmen des Unternehmens zu geben.
Interessierte Parteien können an der Telefonkonferenz teilnehmen, indem sie 1-877-407-0724 (USA) oder 1-201-389-0898 (International) wählen. Darüber hinaus wird ein Live-Webcast sowie ein archivierter Webcast im Investorenbereich der BiomX-Website unter www.biomx.com verfügbar sein.
- None.
- None.
GAITHERSBURG, Md., Aug. 08, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Thursday, August 15, 2024, at 8:00 a.m. ET, to report second quarter 2024 financial results and provide business and program updates.
To participate in the conference call, please dial 1-877-407-0724 (U.S.) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company’s website at www.biomx.com.
About BiomX
BiomX is a clinical-stage company leading the development of natural and engineered phage cocktails and personalized phage treatments designed to target and destroy harmful bacteria for the treatment of chronic diseases with substantial unmet needs. BiomX discovers and validates proprietary bacterial targets and applies its BOLT (“BacteriOphage Lead to Treatment”) platform to customize phage compositions against these targets. For more information, please visit www.biomx.com, the content of which does not form a part of this press release.
BiomX, Inc.
Assaf Oron
+97254-2228901
assafo@biomx.com
FAQ
When will BiomX (PHGE) report its Q2 2024 financial results?
How can investors participate in BiomX's (PHGE) Q2 2024 earnings call?
What is BiomX's (PHGE) main focus as a clinical-stage company?
Where can I find the webcast for BiomX's (PHGE) Q2 2024 earnings call?
